José G. Merino
doi : 10.1212/WNL.0000000000012974
vol. 97 no. 24 1099-1100
José G. Merino
doi : 10.1212/WNL.0000000000013054
vol. 97 no. 24 1101-1102
Roland D. Thijs, Josemir W. Sander
doi : 10.1212/WNL.0000000000012948
vol. 97 no. 24 1103-1104
Shobi Sivathamboo, Daniel Friedman, Juliana Laze, Russell Nightscales, Zhibin Chen, Levin Kuhlmann, Sasha Devore, Vaughan Macefield, Patrick Kwan, Wendyl D'Souza, Samuel F. Berkovic, Piero Perucca, Terence J. O'Brien, Orrin Devinsky, on behalf of the MS-BioS Study Group
doi : 10.1212/WNL.0000000000012946
vol. 97 no. 24 e2357-e2367
We compared heart rate variability (HRV) in sudden unexpected death in epilepsy (SUDEP) cases and living epilepsy controls.
Wyatt P. Bensken, Guadalupe Fernandez-Baca Vaca, Barbara C. Jobst, Scott M. Williams, Kurt C. Stange, Martha Sajatovic, Siran M. Koroukian
doi : 10.1212/WNL.0000000000012975
vol. 97 no. 24 e2368-e2380
People with epilepsy, one-third of whom in the United States are on Medicaid, experience a wide range of chronic and physical comorbidities that influence their care and outcomes. In this study, we examine the burden and racial/ethnic disparities of chronic and acute conditions, injuries, and symptoms in a large and diverse group of people with epilepsy on Medicaid.
Sokratis Charisis, Eva Ntanasi, Mary Yannakoulia, Costas A. Anastasiou, Mary H. Kosmidis, Efthimios Dardiotis, Antonios N. Gargalionis, Kostas Patas, Stylianos Chatzipanagiotou, Ioannis Mourtzinos, Katerina Tzima, Georgios Hadjigeorgiou, Paraskevi Sakka, Dimitrios Kapogiannis, Nikolaos Scarmeas
doi : 10.1212/WNL.0000000000012973
vol. 97 no. 24 e2381-e2391
Aging is characterized by a functional shift of the immune system toward a proinflammatory phenotype. This derangement has been associated with cognitive decline and has been implicated in the pathogenesis of dementia. Diet can modulate systemic inflammation; thus, it may be a valuable tool to counteract the associated risk for cognitive impairment and dementia. The present study aimed to explore the associations between the inflammatory potential of diet, assessed with an easily applicable, population-based, biomarker-validated diet inflammatory index (DII), and the risk for dementia in community-dwelling older adults.
Shahar Shelly, Christopher J. Klein, P. James B. Dyck, Pritikanta Paul, Michelle L. Mauermann, Sarah E. Berini, Benjamin Howe, James P. Fryer, Eati Basal, Hammami M. Bakri, Ruple S. Laughlin, Andrew McKeon, Sean J. Pittock, John Mills, Divyanshu Dubey
doi : 10.1212/WNL.0000000000012932
vol. 97 no. 24 e2392-e2403
Multiple studies highlighting the diagnostic utility of neurofascin-155 (NF155)–immunoglobulin G4 (IgG4) in chronic demyelinating inflammatory polyradiculoneuropathy (CIDP) have been published. However, few studies comprehensively address the long-term outcomes or clinical utility of NF155–immunoglobulin M (IgM) or NF155–immunoglobulin G (IgG) in the absence of NF155-IgG4. We evaluated phenotypic and histopathologic specificity and differences in outcomes between these NF155 antibody isotypes or IgG subclasses. We also compare NF155-IgG4-seropositive cases to other seropositive demyelinating neuropathies.
Lu Yang, Ya-Ru Shao, Xiao-Yan Li, Yin Ma, Yi Dong, Zhi-Ying Wu
doi : 10.1212/WNL.0000000000012945
vol. 97 no. 24 e2404-e2413
Few biochemical markers have been identified in spinocerebellar ataxia type 2 (SCA2). This study aimed to determine the levels of neurofilament light (NfL) in patients with SCA2 and to identify whether they are associated with disease severity.
Melissa B. Pergakis, Wan-Tsu W. Chang, Ali Tabatabai, Michael S. Phipps, Benjamin Neustein, Jamie E. Podell, Gunjan Parikh, Neeraj Badjatia, Melissa Motta, David P. Lerner, Nicholas A. Morris
doi : 10.1212/WNL.0000000000012972
vol. 97 no. 24 e2414-e2422
Multidisciplinary acute stroke teams improve acute ischemic stroke management but may hinder trainees' education, which in turn may contribute to poorer outcomes in community hospitals on graduation. Our goal was to assess graduate neurology trainee performance independently of a multidisciplinary stroke team in the management of acute ischemic stroke, tissue plasminogen activator (tPA)–related hemorrhage, and cerebral herniation syndrome.
Luísa Sousa, Teresa Coelho, Ricardo Taipa
doi : 10.1212/WNL.0000000000012965
vol. 97 no. 24 1111-1119
Hereditary transthyretin amyloidosis (ATTRv amyloidosis) is predominantly a disease of the peripheral nerves, heart, kidney, and eye. CNS involvement has been a marginal issue in research and the clinical setting until recently. Growing evidence shows that leptomeningeal amyloid accumulation is frequent and present from early stages of ATTRv amyloidosis. Several recent studies show CNS symptoms arise as a common late complication in patients with the V30M mutation after at least 14 years of symptomatic peripheral nerve disease. Conversely, in non-V30M patients, there are several descriptions, mostly case reports, of patients presenting with severe phenotypes of ocular and CNS dysfunction (oculoleptomeningeal amyloidosis), with little systemic involvement. This phenotype is found in rare families worldwide, associated with at least 14 mutations. In both patients with late and early onset CNS dysfunction, symptoms include transient focal neurologic episodes, hemorrhagic and ischemic stroke, cognitive decline, and cranial nerve dysfunction. Pathologically, there is severe amyloid deposition in the leptomeninges and cerebral amyloid angiopathy of leptomeningeal and penetrating vessels. These amyloid aggregates are formed mostly by CSF-produced transthyretin (TTR) and seem resistant to the available ATTRv therapies that increase the stability or reduce the production of plasma TTR. This indicates that CNS involvement will become a meaningful issue in patient management in upcoming years.
Lyell K. Jones, Robert A. Gross
doi : 10.1212/WNL.0000000000012977
vol. 97 no. 24 1120
Nicholas E. Johnson, Ericka Greene
doi : 10.1212/WNL.0000000000012976
vol. 97 no. 24 1121-1127
Therapeutic development has accelerated rapidly in the past 5 years in many neurologic and neurodegenerative diseases. The therapeutic categories of development include small molecules, genetic therapies, and cell-based therapies. Current development has provided novel treatment approaches to disorders without available treatment. However, the regulatory procedures to allow for access to these therapies is challenging, as is the ability to provide wide access to increasingly expensive therapies. By 2035, these challenges are likely to have accelerated and have the potential to create bottlenecks in drug approval and reduced access to patients. Innovative regulatory and payer solutions are required. In addition, ethical considerations around genetic therapies should be considered in current and future development. These approaches will ensure that patients with neurologic disease have broad access to highly innovative therapies.
Roy E. Strowd, Whitley Aamodt
doi : 10.1212/WNL.0000000000012980
vol. 97 no. 24 1132-1133
Tara Cook, Robert Arnold, Kwonho Jeong, Julie Childers
doi : 10.1212/WNL.0000000000012911
vol. 97 no. 24 1134-1137
Many neurologic diseases are life limiting and markedly impair patients' quality of life. Growing recommendations in the field recommend that neurologists have primary skills in palliative medicine that will allow them to manage symptoms and discuss end-of-life decisions with patients and families. Previous work has shown that formal palliative care training in neurology residencies is very limited. In this article, we briefly describe a national survey of neurology residents where we assess both the quantity and quality of the teaching they receive in end-of-life care as compared to a common and an uncommon neurologic condition. Based on the gaps we identified, as well as previous studies and recommendations in neuropalliative care, we provide 9 recommendations to help neurology residency programs improve their teaching of primary neuropalliative care skills.
Junyu Lin, Yanbing Hou, Huifang Shang
doi : 10.1212/WNL.0000000000012756
vol. 97 no. 24 e2423-e2428
Progressive spastic paraplegia is the core symptom of hereditary spastic paraplegias (HSPs), a group of monogenic disorders characterized pathologically by degeneration of the corticospinal tract and dorsal column and leading to irreversible neurologic deficits. However, acquired causes, such as structural, vascular, inflammatory, infectious, metabolic, toxic, neurodegenerative, and iatrogenic causes, can also cause acquired spastic paraplegia. We describe the case of a middle-aged man presenting with progressive spastic paraplegia combined with ataxia and parkinsonism. No mutation of HSP genes was detected. After a comprehensive diagnostic workup, hyperintensities in the bilateral basal ganglia, mesencephalon, pons, and cerebellum on T1-weighted images were found, which demonstrated hypointensity on susceptibility-weighted imaging. Furthermore, an increased blood ammonia level and diffuse slow-wave activity in EEG were detected. The patient had a 7-year history of hypertension, alcoholic liver cirrhosis, and transjugular intrahepatic portosystemic shunt operation 2 years before the onset of spastic paraplegia symptoms. Current workup combined with patient history resulted in a diagnosis of acquired hepatocerebral degeneration and hepatic myelopathy.. This case provided a detailed diagnostic approach for progressive spastic paraplegias and exhaustive differential diagnoses of basal ganglia deposits. The take-home message from this case was that acquired causes, especially curable causes, should always be excluded first when dealing with patients with progressive spastic paraplegia.
Anjiao Peng, Yusha Tang, Tingting Song, Lei Chen
doi : 10.1212/WNL.0000000000012666
vol. 97 no. 24 e2429-e2430
Aldo F. Costa, Alba Rodríguez, Paula Martínez, Del Carmen M. Blanco
doi : 10.1212/WNL.0000000000012859
vol. 97 no. 24 e2431-e2432
Ariane Lewis, Steven Galetta
doi : 10.1212/WNL.0000000000012979
vol. 97 no. 24 1138
Fabio S. Taccone, Giuseppe Citerio
doi : 10.1212/WNL.0000000000012981
vol. 97 no. 24 1138-1139
Petra Opic, Raoul Sutter
doi : 10.1212/WNL.0000000000012983
vol. 97 no. 24 1139
Merlin D. Larson
doi : 10.1212/WNL.0000000000012982
vol. 97 no. 24 1140
Petra Opic, Raoul Sutter
doi : 10.1212/WNL.0000000000012984
vol. 97 no. 24 1140-1141
doi : 10.1212/WNL.0000000000013032
vol. 97 no. 24 1141
آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟